ClinVar Genomic variation as it relates to human health
NM_032782.5(HAVCR2):c.245A>G (p.Tyr82Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(5); Benign(1)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_032782.5(HAVCR2):c.245A>G (p.Tyr82Cys)
Variation ID: 626252 Accession: VCV000626252.19
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 5q33.3 5: 157106776 (GRCh38) [ NCBI UCSC ] 5: 156533787 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 29, 2019 Nov 24, 2024 May 23, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_032782.5:c.245A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_116171.3:p.Tyr82Cys missense NM_032782.4:c.245A>G NC_000005.10:g.157106776T>C NC_000005.9:g.156533787T>C NG_030444.1:g.7462A>G - Protein change
- Y82C
- Other names
-
HAVCR2, TYR82CYS (rs184868814)
p.Tyr82Cys
- Canonical SPDI
- NC_000005.10:157106775:T:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00619 (C)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00008
The Genome Aggregation Database (gnomAD) 0.00159
Trans-Omics for Precision Medicine (TOPMed) 0.00220
Exome Aggregation Consortium (ExAC) 0.00345
The Genome Aggregation Database (gnomAD), exomes 0.00383
1000 Genomes Project 30x 0.00609
1000 Genomes Project 0.00619
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
HAVCR2 | - | - |
GRCh38 GRCh37 |
37 | 56 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Conflicting interpretations of pathogenicity (4) |
criteria provided, conflicting classifications
|
May 23, 2024 | RCV001785721.15 | |
Uncertain significance (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 30, 2023 | RCV000768411.6 | |
HAVCR2-related disorder
|
Likely benign (1) |
no assertion criteria provided
|
Oct 18, 2019 | RCV003955498.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Nov 16, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002028049.2
First in ClinVar: Nov 29, 2021 Last updated: Mar 04, 2023 |
Comment:
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in homozygous state in multiple unrelated individuals of East … (more)
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in homozygous state in multiple unrelated individuals of East Asian and Polynesian ancestry with SPTCL in published literature (Gayden et al., 2018), but was also observed in the homozygous state in healthy controls (Lek et al., 2016); This variant is associated with the following publications: (PMID: 30792187, 30374066, 32005988) (less)
|
|
Uncertain significance
(Mar 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Subcutaneous panniculitis-like T-cell lymphoma
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002786618.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Uncertain significance
(Oct 30, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Subcutaneous panniculitis-like T-cell lymphoma
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003810657.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Benign
(Sep 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004157903.10
First in ClinVar: Nov 20, 2023 Last updated: Oct 20, 2024 |
Comment:
HAVCR2: BS1, BS2
Number of individuals with the variant: 1
|
|
Uncertain significance
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005188714.1
First in ClinVar: Aug 18, 2024 Last updated: Aug 18, 2024 |
|
|
Uncertain significance
(May 23, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV005411928.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
BS1, PM3, PS3_moderate, PS4_moderate
Number of individuals with the variant: 1
|
|
risk factor
(Apr 12, 2024)
|
no assertion criteria provided
Method: literature only
|
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE, SUSCEPTIBILITY TO
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000899166.2
First in ClinVar: Apr 29, 2019 Last updated: Apr 20, 2024 |
Comment on evidence:
In 9 patients from 7 unrelated families of East Asian origin with subcutaneous panniculitis-like T-cell lymphoma (SPTCL; 618398), Gayden et al. (2018) identified a homozygous … (more)
In 9 patients from 7 unrelated families of East Asian origin with subcutaneous panniculitis-like T-cell lymphoma (SPTCL; 618398), Gayden et al. (2018) identified a homozygous germline c.245A-G transition (c.245A-G, NM_032782) in the HAVCR2 gene, resulting in a tyr82-to-cys (Y82C) substitution at a highly conserved residue in the IgV domain, which is critical for terminating immune responses. The variant, which was found by whole-exome sequencing and confirmed by targeted sequencing, was found at a low frequency (0.0036) in the gnomAD database, with a higher prevalence among East Asians (minor allele frequency of 0.02104). The mutation segregated in the families from whom parental DNA was available, and heterozygous carriers were unaffected. Four individuals in the ExAC database were homozygous for the variant (3 East Asian and 1 Latino), but it was not possible to contact these individuals for phenotypic information. Heterozygosity for the variant was found in 8 of 107 control individuals from Tahiti (Polynesia) (allele frequency of 4 x 10(-2)). Haplotype analysis showed at least 12 distinct chromosomal backgrounds carrying the variant, suggesting that it is recurrent, although several patients carried a haplotype with evidence of a founder effect in the East Asian population. In patient panniculitis biopsies, mutant HAVCR2 showed abnormal intracellular aggregate staining in the peri-Golgi apparatus with limited plasma expression compared to wildtype. Peripheral monocytes from several patients showed absent HAVCR2 expression, and there was absent expression on activated CD4+ and CD8+ lymphocytes. Heterozygous carriers had an intermediate level of membrane expression. Decreased membrane expression of the mutant protein was confirmed after transfection of the mutation in HEK293 cells. In vitro functional expression studies indicated that the mutant protein was improperly folded and had disrupted posttranslational glycosylation, resulting in improper expression at the cell surface. Polprasert et al. (2019) identified a homozygous Y82C mutation in 10 unrelated patients from Thailand or Japan with SPTCL. Another patient was compound heterozygous for Y82C and a c.302C-T transition in the HAVCR2 gene, resulting in a thr101-to-ile (T101I; 606652.0003) substitution at a highly conserved residue in the IgV-like domain. The mutations were found by whole-exome sequencing and confirmed by deep sequencing. The Y82C variant had a mean allele frequency of 3.6 x 10(-3) in the gnomAD database, with enrichment among East Asians (2.1 x 10(-2)). The T101I variant had a mean allele frequency of 6.6 x 10(-3) in gnomAD, and was enriched among South Asians (1.8 x 10(-3)). Functional studies of the variants and studies of the effects of the mutation on HAVCR2 in patient cells were not performed. (less)
|
|
Likely benign
(Oct 18, 2019)
|
no assertion criteria provided
Method: clinical testing
|
HAVCR2-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004767476.2
First in ClinVar: Mar 16, 2024 Last updated: Oct 08, 2024 |
Comment:
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children. | Zhang Q | British journal of haematology | 2023 | PMID: 37062931 |
Subcutaneous Panniculitis-like T-cell Lymphoma with a HAVCR2 Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis. | Yamamoto Y | Internal medicine (Tokyo, Japan) | 2023 | PMID: 36171125 |
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling. | Zhang Y | Frontiers in oncology | 2022 | PMID: 36212426 |
The genetic structure of the Turkish population reveals high levels of variation and admixture. | Kars ME | Proceedings of the National Academy of Sciences of the United States of America | 2021 | PMID: 34426522 |
Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees. | Nguyen MC | Pediatric blood & cancer | 2021 | PMID: 34398505 |
Subcutaneous panniculitis-like T-cell lymphoma in a 14-year-old female homozygous for HAVCR2 mutation. | Frederiks AJ | The Australasian journal of dermatology | 2021 | PMID: 34398459 |
HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. | Sonigo G | Blood | 2020 | PMID: 32005988 |
Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. | Polprasert C | Blood advances | 2019 | PMID: 30792187 |
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. | Gayden T | Nature genetics | 2019 | PMID: 30429576 |
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. | Gayden T | Nature genetics | 2018 | PMID: 30374066 |
Text-mined citations for rs184868814 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.